Cargando…

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

BACKGROUND: We aimed to investigate the clinical correlates of principal components (PCs) of tau positron emission tomography (PET) and their predictability for longitudinal changes in tau accumulation in Alzheimer’s disease (AD). METHODS: We enrolled 272 participants who underwent two PET scans [(1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Hanna, Baek, Min Seok, Lee, Hye Sun, Lee, Jae Hoon, Ryu, Young Hoon, Lyoo, Chul Hyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513482/ https://www.ncbi.nlm.nih.gov/pubmed/32967721 http://dx.doi.org/10.1186/s13195-020-00685-4

Ejemplares similares

Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms
por: Lyoo, Chul Hyoung, et al.
Publicado: (2018)

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
por: Baek, Min Seok, et al.
Publicado: (2020)

Dynamic network model reveals distinct tau spreading patterns in early- and late-onset Alzheimer disease
por: Lee, Wha Jin, et al.
Publicado: (2022)

Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
por: Therriault, Joseph, et al.
Publicado: (2022)

Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging
por: Ossenkoppele, Rik, et al.
Publicado: (2021)

A Computed Tomography-Based Spatial Normalization for the Analysis of [(18)F] Fluorodeoxyglucose Positron Emission Tomography of the Brain
por: Cho, Hanna, et al.
Publicado: (2014)

Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image
por: Kim, Jin Su, et al.
Publicado: (2015)

Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
por: Janelidze, Shorena, et al.
Publicado: (2020)

Effect of A/T/N imaging biomarkers on impaired odor identification in Alzheimer's disease
por: Baek, Min Seok, et al.
Publicado: (2020)

Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
por: Leuzy, Antoine, et al.
Publicado: (2021)

Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies
por: Maschio, Cinzia, et al.
Publicado: (2022)

Tau positron emission tomography in patients with cognitive impairment and suspected Alzheimer’s disease
por: Matsuda, Hiroshi, et al.
Publicado: (2023)

Tau Filaments and the Development of Positron Emission Tomography Tracers
por: Goedert, Michel, et al.
Publicado: (2018)

Topographic staging of tau positron emission tomography images
por: Schwarz, Adam J., et al.
Publicado: (2018)

Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
por: Wang, Yi Ting, et al.
Publicado: (2019)

Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies
por: Chen, Qin, et al.
Publicado: (2022)

Characterization of an APP/tau rat model of Alzheimer’s disease by positron emission tomography and immunofluorescent labeling
por: Filip, Thomas, et al.
Publicado: (2021)

Escalation of Tau Accumulation after a Traumatic Brain Injury: Findings from Positron Emission Tomography
por: Mohamed, Abdalla Z., et al.
Publicado: (2022)

A Dextral Primary Progressive Aphasia Patient with Right Dominant Hypometabolism and Tau Accumulation and Left Dominant Amyloid Accumulation
por: Jang, Young Kyoung, et al.
Publicado: (2016)

Positron emission tomography of tau in Iraq and Afghanistan Veterans with blast neurotrauma
por: Robinson, Meghan E., et al.
Publicado: (2019)

Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer’s disease
por: Ossenkoppele, Rik, et al.
Publicado: (2020)

Functional Abnormality Associated With Tau Deposition in Alzheimer’s Disease – A Hybrid Positron Emission Tomography/MRI Study
por: Fu, Liping, et al.
Publicado: (2021)

(18)F-APN-1607 Tau Positron Emission Tomography Imaging for Evaluating Disease Progression in Alzheimer’s Disease
por: Xu, Xiaojun, et al.
Publicado: (2022)

Sex differences in off-target binding using tau positron emission tomography
por: Smith, Ruben, et al.
Publicado: (2021)

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer’s Disease Using [(18)F]THK-5117 Positron Emission Tomography
por: Ishiki, Aiko, et al.
Publicado: (2015)

Imaging tau pathology in Alzheimer’s disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies
por: Moscoso, Alexis, et al.
Publicado: (2022)

Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross‐Sectional Tau Positron Emission Tomography
por: Josephs, Keith A., et al.
Publicado: (2022)

The hippocampal sparing subtype of Alzheimer’s disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review
por: Ferreira, Daniel, et al.
Publicado: (2022)

Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
por: Leuzy, Antoine, et al.
Publicado: (2023)

Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding
por: Lemoine, Laetitia, et al.
Publicado: (2018)

Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective
por: Ricci, Maria, et al.
Publicado: (2021)

Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms
por: Smith, Ruben, et al.
Publicado: (2023)

Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
por: Duka, Valeriy, et al.
Publicado: (2013)

Deep learning application for the classification of Alzheimer’s disease using (18)F-flortaucipir (AV-1451) tau positron emission tomography
por: Park, Sang Won, et al.
Publicado: (2023)

Evaluation of principal component analysis-based data-driven respiratory gating for positron emission tomography
por: Walker, Matthew D, et al.
Publicado: (2018)

Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease
por: Ossenkoppele, Rik, et al.
Publicado: (2020)

AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2016)

Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases
por: Krishnadas, Natasha, et al.
Publicado: (2022)

Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity
por: Costoya-Sánchez, Alejandro, et al.
Publicado: (2023)

Dissociation of Tau Deposits and Brain Atrophy in Early Alzheimer’s Disease: A Combined Positron Emission Tomography/Magnetic Resonance Imaging Study
por: Shigemoto, Yoko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fssgpou85i0juqr20vhtnjg2c4